Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Aug 8, 2013 · 10-Q · 39 days after period end · 0001193125-13-326864
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Net Income | -$8.42M | -$4.22M | -$6.53M | $154.00K |
| EPS Diluted | -$0.57 | -$0.29 | -$0.67 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 8, 2013 · 39 d after period end
